About AdaptHealth Corp.
https://adapthealth.comAdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States.
CEO
Suzanne M. Foster
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 159
Ratings Snapshot
Rating : A-
Most Recent Analyst Grades
Grade Summary
Showing Top 5 of 5
Price Target
Institutional Ownership
BLACKROCK, INC.
Shares:15.25M
Value:$160.74M
OEP CAPITAL ADVISORS, L.P.
Shares:13.82M
Value:$145.64M
BLACKROCK INC.
Shares:13.58M
Value:$143.09M
Summary
Showing Top 3 of 256
About AdaptHealth Corp.
https://adapthealth.comAdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $820.31M ▲ | $85.91M ▲ | $22.45M ▲ | 2.74% ▲ | $0.17 ▲ | $170.94M ▼ |
| Q2-2025 | $591.81M ▲ | $-133.16M ▼ | $14.67M ▲ | 2.48% ▲ | $0.1 ▲ | $171.61M ▲ |
| Q1-2025 | $580.47M ▼ | $-100.14M ▼ | $-7.21M ▼ | -1.24% ▼ | $-0.05 ▼ | $117.52M ▼ |
| Q4-2024 | $856.64M ▲ | $230.2M ▲ | $50.26M ▲ | 5.87% ▲ | $0.34 ▲ | $190.98M ▲ |
| Q3-2024 | $597.55M | $-147.8M | $22.86M | 3.83% | $0.16 | $154.22M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $80.36M ▲ | $4.38B ▲ | $2.76B ▲ | $1.62B ▲ |
| Q2-2025 | $68.63M ▲ | $4.35B ▼ | $2.76B ▼ | $1.59B ▲ |
| Q1-2025 | $53.65M ▼ | $4.44B ▼ | $2.86B ▼ | $1.57B ▼ |
| Q4-2024 | $109.75M ▲ | $4.49B ▲ | $2.91B ▼ | $1.57B ▲ |
| Q3-2024 | $100.18M | $4.47B | $2.95B | $1.52B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $22.45M ▲ | $161.07M ▼ | $-92.74M ▼ | $-56.6M ▲ | $11.73M ▼ | $66.82M ▼ |
| Q2-2025 | $15.83M ▲ | $161.99M ▲ | $9.6M ▲ | $-156.62M ▼ | $14.98M ▲ | $73.33M ▲ |
| Q1-2025 | $-6.08M ▼ | $95.53M ▼ | $-95.58M ▼ | $-56.04M ▼ | $-56.1M ▼ | $-58K ▼ |
| Q4-2024 | $51.4M ▲ | $150.41M ▲ | $-86.87M ▼ | $-53.98M ▲ | $9.57M ▼ | $73.08M ▼ |
| Q3-2024 | $27.73M | $144.41M | $-54.24M | $-59.82M | $30.35M | $84.85M |
Revenue by Products
| Product | Q3-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 Respiratory Health | $0 ▲ | $170.00M ▲ | $170.00M ▲ | $180.00M ▲ |
 Health Care Other | $70.00M ▲ | $0 ▼ | $0 ▲ | $0 ▲ |
CEO
Suzanne M. Foster
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 159
Ratings Snapshot
Rating : A-
Most Recent Analyst Grades
Grade Summary
Showing Top 5 of 5
Price Target
Institutional Ownership
BLACKROCK, INC.
Shares:15.25M
Value:$160.74M
OEP CAPITAL ADVISORS, L.P.
Shares:13.82M
Value:$145.64M
BLACKROCK INC.
Shares:13.58M
Value:$143.09M
Summary
Showing Top 3 of 256